Prostate cancer: utility of fusion of T2-weighted and high b-value diffusion-weighted images for peripheral zone tumor detection and localization.
about
Prostate specific antigen: the past, present and future.Whole body MRI: improved lesion detection and characterization with diffusion weighted techniquesImaging and intervention in prostate cancer: Current perspectives and future trendsDiffusion-weighted MRI and its role in prostate cancer.Diffusion-weighted MR imaging in gynecologic cancers.Consistency of T2WI-FS/ASL fusion images in delineating the volume of nasopharyngeal carcinoma.Short-term reproducibility of apparent diffusion coefficient estimated from diffusion-weighted MRI of the prostatePreliminary experience with a novel method of three-dimensional co-registration of prostate cancer digital histology and in vivo multiparametric MRI.Comparison of T2(*) mapping with diffusion-weighted imaging in the characterization of low-grade vs intermediate-grade and high-grade prostate cancer.The value of diffusion-weighted imaging in the detection of prostate cancer: a meta-analysis.Validation of the Dominant Sequence Paradigm and Role of Dynamic Contrast-enhanced Imaging in PI-RADS Version 2.Detection of prostate cancer in peripheral zone: comparison of MR diffusion tensor imaging, quantitative dynamic contrast-enhanced MRI, and the two techniques combined at 3.0 T.The diagnostic accuracy of high b-value diffusion- and T2-weighted imaging for the detection of prostate cancer: a meta-analysis.Clinically insignificant prostate cancer suitable for active surveillance according to Prostate Cancer Research International: Active surveillance criteria: Utility of PI-RADS v2.Detectability of low and intermediate or high risk prostate cancer with combined T2-weighted and diffusion-weighted MRI.Myometrial invasion and overall staging of endometrial carcinoma: assessment using fusion of T2-weighted magnetic resonance imaging and diffusion-weighted magnetic resonance imaging.Optimal high b-value for diffusion weighted MRI in diagnosing high risk prostate cancers in the peripheral zone.
P2860
Q30436923-72ECD6C5-F0FB-46A3-AA40-CB155D533F57Q30662431-9841C8C2-4313-4F53-B386-36DE0CCC7A14Q33891781-09D451EF-1473-4433-AF21-BC3209903F72Q34742733-56FBD5E6-6A61-40B5-B301-D3CDF54FD330Q35663658-3EFEED2E-1818-419F-B1CD-889717B95EB0Q36376149-747FDD6B-3488-4680-9723-ECBEF16F80D6Q37032783-CAA2C2B2-B629-4D36-A557-323DBEF1E51CQ37447030-509BF43A-7002-4F79-BB21-9B76CB030CA8Q37600905-A61EA376-624C-4D5E-AF24-5448F58B02C3Q38215292-876D6E6D-8FD2-466C-9C2D-CE42C8521AE9Q38670271-53D9316E-6F17-4A0F-945D-38D9B6B95385Q43525988-C06777D8-3C1C-4922-BF8B-6DA39A3B1273Q47410159-D70C16A2-2019-4A6B-9C5E-7EC2E6818C32Q47681129-E526B499-98FB-42A8-8EEC-97F04B6BADEFQ47955825-716ED7EE-EA7E-4145-9608-0018BA08F27AQ48526495-97723D3E-6E6D-4038-84CB-40676213E538Q52981879-18ECFB23-CCA6-4C2F-AE5D-125796D7DE25
P2860
Prostate cancer: utility of fusion of T2-weighted and high b-value diffusion-weighted images for peripheral zone tumor detection and localization.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh
2011年學術文章
@zh-hant
name
Prostate cancer: utility of fu ...... or detection and localization.
@en
Prostate cancer: utility of fu ...... or detection and localization.
@nl
type
label
Prostate cancer: utility of fu ...... or detection and localization.
@en
Prostate cancer: utility of fu ...... or detection and localization.
@nl
prefLabel
Prostate cancer: utility of fu ...... or detection and localization.
@en
Prostate cancer: utility of fu ...... or detection and localization.
@nl
P2093
P2860
P50
P356
P1476
Prostate cancer: utility of fu ...... mor detection and localization
@en
P2093
Ben E Niver
Douglas S Berkman
James S Babb
Samir S Taneja
Xiangtian Kong
P2860
P304
P356
10.1002/JMRI.22598
P577
2011-07-01T00:00:00Z